Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective – A systematic review of recently published literature on real-world data-Reference-Cited by-同舟云学术

Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective – A systematic review of recently published literature on real-world data

Published:2022-05 Issue:22 Volume:40 Page:2999-3008
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gärtner B.C.,Weinke T.,Wahle K.,Kwetkat A.,Beier D.,Schmidt K.J.,Schwarz T.F.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference64 articles.

1. Centers for Disease Control and Prevention (CDC). How flu vaccine effectiveness and efficacy are measured. https://www.cdc.gov/flu/vaccines-work/effectivenessqa.htm; 2016 [accessed 3 August 2021].

2. Gavi. What is the difference between efficacy and effectiveness? https://www.gavi.org/vaccineswork/what-difference-between-efficacy-and-effectiveness; 2020 [accessed 5 August 2021].

3. World Health Organization (WHO). Vaccine efficacy, effectiveness and protection. https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection; 2021 [accessed 5 August 2021].

4. McNeil. Overview of Vaccine Efficacy and Vaccine Effectiveness. https://www.who.int/influenza_vaccines_plan/resources/Session4_VEfficacy_VEffectiveness.PDF [accessed 25 August 2021].

5. World Health Organization (WHO). Evaluation of COVID-19 vaccine effectiveness: Interim guidance. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1; 2021 [accessed 2 September 2021].

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial;Clinical Infectious Diseases;2024-08-05

2. Impfen bei pneumologischen Erkrankungen – was, wann und wie?;DMW - Deutsche Medizinische Wochenschrift;2024-08

3. Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France;Vaccines;2024-05-24

4. Use of Adjuvanted Quadrivalent Influenza Vaccine in Older-Age Adults: A Systematic Review of Economic Evidence;Vaccines;2024-05-10

5. Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines;Human Vaccines & Immunotherapeutics;2024-04-15